Prostate fusion biopsy

Prostate fusion biopsy is the most modern diagnostic test for prostate

cancer. The patient receives a result in 3D technology - a fusion of a TRUS ultrasound image and a magnetic resonance image. The obtained image eliminates possible deformations resulting from the movement of soft tissues during resonance and biopsy that are performed simultaneously. This innovative procedure is completely safe for the patient and is performed percutaneously through the perineum rather than through the rectum. It takes place under intravenous anesthesia in a hospital setting and lasts only about 2.5 hours. The risk of diagnostic complications is reduced to a minimum, including the risk of sepsis which is less than 0.01%. The procedure is performed by doctor Stefan W. Czarniecki - Leader of Modern Diagnostics, who has already performed over 1,000 prostate biopsies.

 

HIFU CLINIC Prostate Cancer Treatment Center is the only medical center in this part of Europe that has a specialized, state-of-the-art Koelis Trinity fusion prostate biopsy system.

What is a prostate fusion biopsy?

Prostate fusion biopsy is a procedure in which tiny samples of the prostate gland tissue are collected. The collected samples are then evaluated by an experienced pathomorphologist under a microscope, often with the addition of various immunohistochemical dyes.

 

Prostate fusion biopsy is performed through the perineum with the use of a TRUS image and a magnetic resonance image. The procedure is carried out by a urologist and a radiologist assisted by a nurse. Fusion biopsy is based on the fusion of multiparameter magnetic resonance images (mpMRI) and real time ultrasound imaging.

 

Since 2015, the European Association of Urology (EAU) recommends that every repeated prostate biopsy should be carried out based on the mpMRI examination and any abnormalities found in it. From 2019, the European Association of Urology (EAU) also recommends that every patient who is considered to undergo prostate biopsy should consider undergoing a prostate MRI first. Magnetic resonance imaging is performed specifically for the purpose of a subsequent prostate fusion biopsy.

 

Prostate fusion biopsy - what is the purpose of the procedure?

The purpose of the prostate fusion biopsy is to confirm or exclude the presence of prostate cancer. It is also used in the active surveillance of prostate cancer that has been already diagnosed.

Prostate fusion biopsy under the control of TRUS and MRI image fusion allows for precise "navigation" during its execution. The outstanding superiority of a fusion biopsy over a simple TRUS biopsy is that the doctor uses the prostate magnetic resonance image to extract specimens from precisely identified suspect areas. Thus, it minimizes the supra-detectability of prostate tumors not clinically relevant and increases the detectability of clinically significant prostate tumors, while at the same time reducing the number of samples that need to be extracted.

The combination of ultrasound imaging and magnetic resonance imaging is one of the most modern diagnostic tools in current day urology.

 

Prostate fusion biopsy - benefits

The most important benefits of a transperineal fusion biopsy include:

  • Painless procedure - the procedure is performed under intravenous anesthesia,
  • Short duration - The patient spends a maximum of 2.5 hours. in the hospital,
  • Safe procedure - the risk of sepsis complications is less than 0.01%,
  • Transperineal biopsy - the procedure is safer and more beneficial for the patient,
  • Precision - allows for a much higher accuracy of detecting a small tumor lesion, accuracy 2-3mm
  • Technologically advanced - Koelis Tritnity is the only TRUS and magnetic resonance image fusion system that compensates for the deformations resulting from the movement of soft tissue during biopsies,
  • Complementary to magnetic resonance imaging - Patients are undergoing prostate magnetic resonance imaging in accordance with the latest guidelines, but only thanks to the fusion biopsy system the diagnosis provided by that test can be fully utilized,
  • An expert procedure - a prostate fusion biopsy at HIFU CLINIC is performed by doctor Stefan W. Czarniecki - Leader of Modern Diagnostics, who performed over 1000 such procedures

 

Prostate fusion biopsy - what should the Patient tell his urologist before the procedure?

Patients who are undergoing a fusion biopsy should perform prior magnetic resonance imaging of the prostate gland.

They should also notify the urologist before performing the procedure about:

 

  • existing diseases related to blood clotting,
  • taking medicines that affect blood coagulation,
  • any drug allergies,
  • implanted pacemakers or artificial heart valves.

 

Where do we perform prostate biopsy?

Prostate fusion biopsy is performed at the HIFU CLINIC Prostate Cancer Treatment Center at Carolina Medical Center, one of the most modern hospitals in Poland.

HIFU CLINIC Prostate Cancer Treatment Center is the only medical center in this part of Europe that utilizes the Koelis Trinity fusion biopsy system the most modern specialist equipment in this part of Europe .

 

Prostate fusion biopsy - how can I make an appointment for a procedure?

In order to consult and determine whether the study is appropriate for you, contact us using our free online consultation. We will be happy to analyze your medical history and answer all your questions.

In order to make an appointment, please contact the Patient Coordination Department at: +48 512 077 461 or +48 512 077 460 or by email: kontakt@hifu.pl.

 

Do you have any questions or need more information?Contact us >>

See also

MRI/TRUS fusion guided targeted prostate biopsy

This procedure is performed in patients with increased PSA levels and when any anomalies are found...

More
4KSCORE® molecular test

4Kscore®Test allows to predict development of clinically significant prostate cancer...

More